Manulife (Manufacturers Life Insurance)’s Acura Pharmaceuticals ACUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-389
Closed 4496
2016
Q4
$0 Hold
389
﹤0.01% 4540
2016
Q3
$1K Hold
389
﹤0.01% 4256
2016
Q2
$1K Hold
389
﹤0.01% 4214
2016
Q1
$1K Hold
389
﹤0.01% 4075
2015
Q4
$1 Hold
389
﹤0.01% 3966
2015
Q3
$1 Sell
389
-1
-0.3% -$3 ﹤0.01% 4007
2015
Q2
$2 Hold
390
﹤0.01% 3855
2015
Q1
$2 Hold
390
﹤0.01% 3847
2014
Q4
$1 Hold
390
﹤0.01% 3889
2014
Q3
$2 Hold
390
﹤0.01% 3805
2014
Q2
$2K Hold
390
﹤0.01% 3731
2014
Q1
$3 Hold
390
﹤0.01% 3608
2013
Q4
$3 Hold
390
﹤0.01% 3642
2013
Q3
$4 Hold
390
﹤0.01% 3434
2013
Q2
$4K Buy
+390
New +$4.41K ﹤0.01% 3332

Other funds holding ACUR

Manulife (Manufacturers Life Insurance)'s ACUR Position: Q1 2017 in Review

Manulife (Manufacturers Life Insurance) sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 389 shares.

Manulife (Manufacturers Life Insurance) first reported a position in ACUR in Q2 2013 and held it in 15 quarters. The position peaked at $4K in Q2 2013. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

  • Manulife (Manufacturers Life Insurance) reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 389 Acura Pharmaceuticals shares in Q1 2017.
  • Manulife (Manufacturers Life Insurance) first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Manulife (Manufacturers Life Insurance)'s Acura Pharmaceuticals position peaked at $4K in Q2 2013.
  • 3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2017, filed 15 May 2017.